Elequin Capital’s Novanta NOVT Stock Holding History

Elequin Capital’s Portfolio NOVT Stock Details NOVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,895	Closed	-$224K	–	850
2026 Q1	$224K	Buy	1,895 +1,513	+396%	+$199K	0.02%	100
2025 Q4	$45.5K	Buy	+382	New	+$43.5K	﹤0.01%	148

Other funds holding NOVT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Elequin Capital's NOVT Position: Q2 2026 in Review

Elequin Capital sold out of Novanta (NOVT) in Q2 2026, closing a stake of 1,895 shares — an estimated $224K sold.

Elequin Capital first reported a position in NOVT in Q4 2025 and held it in 2 quarters. The position peaked at $224K in Q1 2026. 391 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

Elequin Capital reported no remaining Novanta position as of Q2 2026 after selling out during the quarter.
Elequin Capital sold 1,895 Novanta shares in Q2 2026, an estimated $224K.
Elequin Capital first reported a position in Novanta in Q4 2025 and held it in 2 quarters.
Elequin Capital's Novanta position peaked at $224K in Q1 2026.
391 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.